Observational studyCardiovascular diabetology2025

SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease.

Ziad Arow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.